Product
Tenofovir disoproxil fumarate/emtricitabine + Cabotegravir
1 clinical trial
1 indication
Indication
HIVClinical trial
Implementing Oral (Event-driven and Daily) and Long-acting Pre-Exposure Prophylaxis in Mobile Men in Sub-Saharan Africa: a Phase 3b, Open-label, Hybrid Type 2 Implementation and Effectiveness TrialStatus: Not yet recruiting, Estimated PCD: 2025-12-31